About Arcturus Therapeutics

Arcturus Therapeutics focuses on developing novel RNA therapeutics for the treatment of various diseases aiming at Rare Diseases. The company owns Unlocked Nucleic Acid (UNA) chemistry technology and patent portfolio (32 patents, USPTO granted) enabling the targeting of any gene in the human genome. It was founded in 2013 and headquartered in San Diego, California.

Company Highlights
Year Founded

2013

icon-altEmployees

204

Location (HQ)

USA

Since Last Funding

11 months

Monthly Website Visitors

8.4K

icon-altTotal Investment Amt

$500M

Last Funding Round

Grant

icon-altMoM Headcount Growth

0.99%

icon-altYoY Headcount Growth

-6.85%

Key Metrics

Senior Hires

NameLinkedin ProfilePositionDate Joined
John Doehttps://www.linkedin.com/in/johndoeCEOCEO
Jane Doehttps://www.linkedin.com/in/janedoeCTOCTO
John Smithhttps://www.linkedin.com/in/johnsmithCFOCFO
Jane Smithhttps://www.linkedin.com/in/janesmithCOOCOO
Get API access to complete private company database with growth metrics from 15 sources

Similar Companies

Therapeutics

Health Care

Biotechnology

Biotechnology Research

Medical

Genetics